Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Overweight in childhood and adolescence: Does it lead to airway hyperresponsiveness in adulthood?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Objective confirmation of asthma diagnosis improves medication adherence

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Novel monoclonal treatments in severe asthma

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Stability of FeNO and airway hyperresponsiveness to mannitol in untreated asthmatics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Are recreational SCUBA divers with asthma at increased risk?

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. Assessment of fitness for recreational scuba diving in candidates with asthma: a pilot study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Precision medicine and treatable traits in chronic airway diseases - where do we stand?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: The mannitol test is widely used for assessment of airway responsiveness in patients with possible asthma, but our knowledge of the value in everyday clinical practice is limited. Objective: To investigate the diagnostic value of the mannitol test in a clinical setting. Methods: All patients having a mannitol challenge test as part of their diagnostic work-up for asthma at the respiratory outpatient clinic, Hvidovre Hospital, over a 5-year period were included in the present analysis. Case history, including previous diagnoses, spirometry, exhaled nitric oxide (F E NO) was obtained. The mannitol challenge was performed according to guidelines, i.e. increasing doses of mannitol (from 5 to 635 mg) until maximum dose or a 15% decline in FEV 1 (PD 15 ) was achieved (positive test defined as a PD 15 < 635 mg). Results: Our cohort comprised 566 patients (210 men). Post-challenge, 247 patients were diagnosed with asthma by a specialist in respiratory medicine, of whom 138 (56%) had a positive mannitol test. A diagnosis of asthma was ruled out by the specialist in 319 individuals, of whom 18 (6%) had a positive mannitol test and 77 (24%) previous doctor-diagnosed asthma (but with no evidence of a confirmatory test). The specificity and sensitivity of the test was 94% and 56%, respectively. Female gender (p = 0.005), increasing BMI (p < 0.001), exercise-induced cough (p = 0.002), night-time respiratory symptoms (p = 0.002), low FEV 1 /FVC ratio (p = 0.008) and high F E NO (p < 0.001) were determinants for a positive mannitol test. Conclusion: In everyday clinical work-up of patients with possible asthma, the sensitivity and specificity of the mannitol challenge test is comparable to previous controlled trials.

OriginalsprogEngelsk
TidsskriftThe Journal of asthma : official journal of the Association for the Care of Asthma
Sider (fra-til)1-7
Antal sider7
ISSN0277-0903
DOI
StatusE-pub ahead of print - 16 apr. 2019

ID: 57016650